122 related articles for article (PubMed ID: 36843266)
1. A Combination of Bio-Orthogonal Supramolecular Clicking and Proximity Chemical Tagging as a Supramolecular Tool for Discovery of Putative Proteins Associated with Laminopathic Disease.
Sim J; Lee A; Kim D; Kim KL; Park BJ; Park KM; Kim K
Small; 2023 May; 19(21):e2208088. PubMed ID: 36843266
[TBL] [Abstract][Full Text] [Related]
2. Proteomic identification of putative biomarkers for early detection of sudden cardiac death in a family with a LMNA gene mutation causing dilated cardiomyopathy.
Izquierdo I; Rosa I; Bravo SB; Guitián E; Pérez-Serra A; Campuzano O; Brugada R; Mangas A; García Á; Toro R
J Proteomics; 2016 Oct; 148():75-84. PubMed ID: 27457270
[TBL] [Abstract][Full Text] [Related]
3. The LMNA mutation p.Arg321Ter associated with dilated cardiomyopathy leads to reduced expression and a skewed ratio of lamin A and lamin C proteins.
Al-Saaidi R; Rasmussen TB; Palmfeldt J; Nissen PH; Beqqali A; Hansen J; Pinto YM; Boesen T; Mogensen J; Bross P
Exp Cell Res; 2013 Nov; 319(19):3010-9. PubMed ID: 24001739
[TBL] [Abstract][Full Text] [Related]
4. Lamin A/C mutations in dilated cardiomyopathy.
Tesson F; Saj M; Uvaize MM; Nicolas H; Płoski R; Bilińska Z
Cardiol J; 2014; 21(4):331-42. PubMed ID: 24846508
[TBL] [Abstract][Full Text] [Related]
5. A novel deletion mutation accompanied by a point mutation in Lamin A/C gene: Screened from a dilated cardiomyopathy family.
Jia H; Sun Y; Yao W; Chen Z; Yang S; Wang C; Lu S
Perfusion; 2023 May; 38(4):826-836. PubMed ID: 35514053
[TBL] [Abstract][Full Text] [Related]
6. Plasma microRNAs as biomarkers for Lamin A/C-related dilated cardiomyopathy.
Toro R; Blasco-Turrión S; Morales-Ponce FJ; Gonzalez P; Martínez-Camblor P; López-Granados A; Brugada R; Campuzano O; Pérez-Serra A; Rosa Longobardo F; Mangas A; Llorente-Cortes V; de Gonzalo-Calvo D
J Mol Med (Berl); 2018 Aug; 96(8):845-856. PubMed ID: 30008018
[TBL] [Abstract][Full Text] [Related]
7. Clinical and functional characterization of a novel mutation in lamin a/c gene in a multigenerational family with arrhythmogenic cardiac laminopathy.
Forleo C; Carmosino M; Resta N; Rampazzo A; Valecce R; Sorrentino S; Iacoviello M; Pisani F; Procino G; Gerbino A; Scardapane A; Simone C; Calore M; Torretta S; Svelto M; Favale S
PLoS One; 2015; 10(4):e0121723. PubMed ID: 25837155
[TBL] [Abstract][Full Text] [Related]
8. A Novel Truncating LMNA Mutation in Patients with Cardiac Conduction Disorders and Dilated Cardiomyopathy.
Kawakami H; Ogimoto A; Tokunaga N; Nishimura K; Kawakami H; Higashi H; Iio C; Kono T; Aono J; Uetani T; Nagai T; Inoue K; Suzuki J; Ikeda S; Okura T; Ohyagi Y; Tabara Y; Higaki J
Int Heart J; 2018 May; 59(3):531-541. PubMed ID: 29628476
[TBL] [Abstract][Full Text] [Related]
9. DNA Damage Response/TP53 Pathway Is Activated and Contributes to the Pathogenesis of Dilated Cardiomyopathy Associated With LMNA (Lamin A/C) Mutations.
Chen SN; Lombardi R; Karmouch J; Tsai JY; Czernuszewicz G; Taylor MRG; Mestroni L; Coarfa C; Gurha P; Marian AJ
Circ Res; 2019 Mar; 124(6):856-873. PubMed ID: 30696354
[TBL] [Abstract][Full Text] [Related]
10. An LMNA synonymous variant associated with severe dilated cardiomyopathy: Case report.
Gao S; Mumme-Monheit A; Chen SN; Spector EB; Slavov D; Baralle FE; Bristow MR; Mestroni L; Taylor MRG;
Am J Med Genet A; 2022 Feb; 188(2):600-605. PubMed ID: 34652067
[TBL] [Abstract][Full Text] [Related]
11. Lamin A/C mutation is independently associated with an increased risk of arterial and venous thromboembolic complications.
van Rijsingen IA; Bakker A; Azim D; Hermans-van Ast JF; van der Kooi AJ; van Tintelen JP; van den Berg MP; Christiaans I; Lekanne Dit Deprez RH; Wilde AA; Zwinderman AH; Meijers JC; Grootemaat AE; Nieuwland R; Pinto YM; Pinto-Sietsma SJ
Int J Cardiol; 2013 Sep; 168(1):472-7. PubMed ID: 23073275
[TBL] [Abstract][Full Text] [Related]
12. Lamin A/C haploinsufficiency causes dilated cardiomyopathy and apoptosis-triggered cardiac conduction system disease.
Wolf CM; Wang L; Alcalai R; Pizard A; Burgon PG; Ahmad F; Sherwood M; Branco DM; Wakimoto H; Fishman GI; See V; Stewart CL; Conner DA; Berul CI; Seidman CE; Seidman JG
J Mol Cell Cardiol; 2008 Feb; 44(2):293-303. PubMed ID: 18182166
[TBL] [Abstract][Full Text] [Related]
13. Expanding the phenotype of LMNA mutations in dilated cardiomyopathy and functional consequences of these mutations.
Sébillon P; Bouchier C; Bidot LD; Bonne G; Ahamed K; Charron P; Drouin-Garraud V; Millaire A; Desrumeaux G; Benaïche A; Charniot JC; Schwartz K; Villard E; Komajda M
J Med Genet; 2003 Aug; 40(8):560-7. PubMed ID: 12920062
[TBL] [Abstract][Full Text] [Related]
14. [Cardiac manifestations of laminopathies].
Brette S; Penisson-Besnier I; Dupuis JM; Bonne G; Victor J
Arch Mal Coeur Vaiss; 2004 Oct; 97(10):973-7. PubMed ID: 16008174
[TBL] [Abstract][Full Text] [Related]
15. Integrated analysis reveals the alterations that LMNA interacts with euchromatin in LMNA mutation-associated dilated cardiomyopathy.
Zhang X; Shao X; Zhang R; Zhu R; Feng R
Clin Epigenetics; 2021 Jan; 13(1):3. PubMed ID: 33407844
[TBL] [Abstract][Full Text] [Related]
16. Familial dilated cardiomyopathy with a novel
Li K; Zhao L; Zhang P
Cardiol Young; 2020 Oct; 30(10):1544-1546. PubMed ID: 32914734
[TBL] [Abstract][Full Text] [Related]
17. Heterozygous LmnadelK32 mice develop dilated cardiomyopathy through a combined pathomechanism of haploinsufficiency and peptide toxicity.
Cattin ME; Bertrand AT; Schlossarek S; Le Bihan MC; Skov Jensen S; Neuber C; Crocini C; Maron S; Lainé J; Mougenot N; Varnous S; Fromes Y; Hansen A; Eschenhagen T; Decostre V; Carrier L; Bonne G
Hum Mol Genet; 2013 Aug; 22(15):3152-64. PubMed ID: 23575224
[TBL] [Abstract][Full Text] [Related]
18. Nuclear accumulation of androgen receptor in gender difference of dilated cardiomyopathy due to lamin A/C mutations.
Arimura T; Onoue K; Takahashi-Tanaka Y; Ishikawa T; Kuwahara M; Setou M; Shigenobu S; Yamaguchi K; Bertrand AT; Machida N; Takayama K; Fukusato M; Tanaka R; Somekawa S; Nakano T; Yamane Y; Kuba K; Imai Y; Saito Y; Bonne G; Kimura A
Cardiovasc Res; 2013 Aug; 99(3):382-94. PubMed ID: 23631840
[TBL] [Abstract][Full Text] [Related]
19. The LMNA p.R541C mutation causes dilated cardiomyopathy in human and mice.
Yang L; Sun J; Chen Z; Liu L; Sun Y; Lin J; Hu X; Zhao M; Ma Y; Lu D; Li Y; Guo Y; Dong E
Int J Cardiol; 2022 Sep; 363():149-158. PubMed ID: 35714719
[TBL] [Abstract][Full Text] [Related]
20. Identification of novel mutations in LMNA associated with familial forms of dilated cardiomyopathy.
Stallmeyer B; Koopmann M; Schulze-Bahr E
Genet Test Mol Biomarkers; 2012 Jun; 16(6):543-9. PubMed ID: 22224630
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
